In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Venous Thromboembolism Following Meningioma Surgery: A Nationwide Population-Based Retrospective Analysis

    Final Number:
    704

    Authors:
    Eleonora F Spinazzi MD; Darshan Shastri MA; Nicole Silva BA; Jean Anderson Eloy MD; James K. Liu MD

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2017 Annual Meeting

    Introduction: Surgical resection of meningiomas has been associated with the highest rates of venous thromboembolic events (VTE) as compared with all other intracranial tumors. The underlying pathophysiological mechanism for this tumor-specific finding remains unclear. There is a paucity of data regarding the clinical complications and comorbidities associated with this cohort. The purpose of this study was to determine the risk factors for VTE in a large cohort of patients with intracranial meningiomas undergoing surgery.

    Methods: This retrospective analysis utilized discharge data from the National Inpatient Sample (NIS) from 2002-2010. Patient demographics, comorbidities, length of stay, hospital charges, and postoperative complications were compared between patients with and without VTE. Cross-tabulation, Pearson’s chi-square tests, Fischer’s exact test, and independent 2-tailed t tests were used where appropriate. Binary logistic regression was performed with various postoperative complications as the dependent variable.

    Results: Of 20,259 patients, 426 (2.1%) experienced a VTE. Compared to the non-VTE cohort, patients that experienced a VTE were older (62.7±13.7 vs. 57.2±14.7; p < 0.001), more commonly male (38.0% vs 30.1%; p = 0.001), had longer hospitalizations (18.8 vs 6.6 days; p < 0.001), and incurred significantly greater hospital charges ($195,837 vs $74,434; p < 0.001). The VTE cohort also had higher comorbidity rates, including congestive heart failure (5.6% vs 2.2%, p < 0.001), hypertension (50.2% vs 45.1%, p < 0.045), diabetes mellitus (20.4% vs 15.7%, p < 0.010), peripheral vascular disorders (2.8% vs 1.2%, p < 0.003), and preexisting coagulopathies (11.7% vs 2.0%; p < 0.001). VTE patients experienced significantly higher rates of acute postoperative complications including shock, hemorrhage, wound dehiscence, infection, intracerebral hemorrhage, hemiparesis/hemiplegia, stroke, and death during admission.

    Conclusions: Occurrence of VTE in patients undergoing meningioma resection portends greater hospital charges, longer lengths of admission, increased postoperative complications and mortality. Neurosurgeons should be aware of this complication risk when treating meningioma patients.

    Patient Care: Venous thromboembolic events (VTE), which include deep vein thrombosis (DVT) and pulmonary embolisms (PE), represent the most common complication observed in patients undergoing meningioma surgery. Development of postoperative VTE has shown to be fatal in over one third of subjects, an aggravating statistic that alone has pushed the medical field to identify potential risk factors associated with this complication. While ample data already exists on specific risks and complications inherent to meningioma surgery, to date little is known about patient-specific factors and their influence on the development and outcome of post-operative VTE. The current study utilizes the National Inpatient Sample (NIS) database, a multi-institutional, population-based resource, to report the prevalence, impact and risk factors of VTE following intracranial meningioma surgery.

    Learning Objectives: 1. To report the prevalence, impact and risk factors of VTE following intracranial meningioma surgery 2. To learn about patient-specific factors and their influence on the development and outcome of post-operative VTE and promote further investigation and wariness of the physician when treating surgical candidates of meningioma. 3.To illustrate the statistical power and external validity obtained when utilizing multi-institutional, population-based resources to investigate of uncommon disorders.

    References: 1. Aghi MK, Eskandar EN, Carter BS, Curry WT, Barker FG: Increased prevalence of obesity and obesity-related postoperative complications in male meningioma patients. Clinical neurosurgery 54:236-240, 2007 2. Alshehri N, Cote DJ, Hulou MM, Alghamdi A, Alshahrani A, Mekary RA, et al: Venous thromboembolism prophylaxis in brain tumor patients undergoing craniotomy: a meta-analysis. Journal of Neuro-Oncology, 2016 3. Alzahrani SH, Ajjan RA: Review article: Coagulation and fibrinolysis in diabetes. Diabetes and Vascular Disease …, 2010 4. Bell EJ, Folsom AR, Lutsey PL, Selvin E: Diabetes mellitus and venous thromboembolism: A systematic review and meta-analysis. Diabetes research and …, 2016 5. Black P, Kathiresan S, Chung W: Meningioma surgery in the elderly: a case-control study assessing morbidity and mortality. Acta neurochirurgica 140:1013, 1998 6. Boviatsis EJ, Bouras TI, Kouyialis AT, Themistocleous MS, Sakas DE: Impact of age on complications and outcome in meningioma surgery. Surgical neurology 68:407, 2007 7. Cage TA, Lamborn KR, Ware ML, Frankfurt A, Chakalian L, Berger MS, et al: Adjuvant enoxaparin therapy may decrease the incidence of postoperative thrombotic events though does not increase the incidence of postoperative intracranial hemorrhage in patients with meningiomas. Journal of neuro-oncology 93:151-156, 2009 8. Christensen DH, Horváth-Puhó E, Thomsen RW, Knudsen STT, Dekkers O, Prandoni P, et al: Venous thromboembolism and risk of cancer in patients with diabetes mellitus. Journal of diabetes and its complications 30:603-607, 2016 9. Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR: Thrombophilia, Clinical Factors, and Recurrent Venous Thrombotic Events. JAMA 293:2352-2361, 2005 10. Cushing H: The meningiomas (dural endotheliomas): their source and favored seats of origin. Brain 45:286-316, 1922 11. Demonte F, McDermott MW: Al-Mefty's Meningiomas: Thieme, 2011 12. Eisenring CV, Neidert MC, Bové D, Held L, Sarnthein J, Krayenbühl N: Reduction of thromboembolic events in meningioma surgery: a cohort study of 724 consecutive patients. PloS one 8, 2013 13. Gerber DE, Segal JB, Salhotra A, Olivi A, Grossman SA, Streiff MB: Venous thromboembolism occurs infrequently in meningioma patients receiving combined modality prophylaxis. Cancer 109:300-305, 2007 14. Helseth A, Tretli S: Pre-morbid height and weight as risk factors for development of central nervous system neoplasms. Neuroepidemiology 8:277-282, 1989 15. Hoefnagel D, Kwee LE, van Putten EH, Kros JM, Dirven CM, Dammers R: The incidence of postoperative thromboembolic complications following surgical resection of intracranial meningioma. A retrospective study of a large single center patient cohort. Clinical neurology and neurosurgery 123:150-154, 2014 16. Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ: Sex steroid hormone exposures and risk for meningioma. Journal of neurosurgery 99:848-853, 2003 17. Kanaan I, Jallu A, Kanaan H: Management Strategy for Meningioma in Pregnancy: A Clinical Study. Skull Base 13:197-204, 2003 18. Konglund A, Rogne SG, Lund-Johansen M, Scheie D, Helseth E, Meling TR: Outcome following surgery for intracranial meningiomas in the aging. Acta neurologica Scandinavica 127:161-169, 2013 19. Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S: The risk of recurrent venous thromboembolism in men and women. The New England journal of medicine 350:2558-2563, 2004 20. Lambe M, Coogan P, Baron J: Reproductive factors and the risk of brain tumors: a population-based study in Sweden. International journal of cancer 72:389-393, 1997 21. Levi AD, Wallace MC, Bernstein M, Walters BC: Venous thromboembolism after brain tumor surgery: a retrospective review. Neurosurgery 28:859-863, 1991 22. Libertiny G, Hands L: Deep venous thrombosis in peripheral vascular disease. The British journal of surgery 86:907-910, 1999 23. Moradiya Y, Murthy SB, Newman-Toker DE, Hanley DF, Ziai WC: Intraventricular thrombolysis in intracerebral hemorrhage requiring ventriculostomy: a decade-long real-world experience. Stroke 45:2629-2635, 2014 24. Moussa WM, Mohamed MA: Prophylactic use of anticoagulation and hemodilution for the prevention of venous thromboembolic events following meningioma surgery. Clinical neurology and neurosurgery 144:1-6, 2016 25. Raikundalia MD, Pines MJ, Svider PF, Baredes S, Folbe AJ, Liu JK, et al: Characterization of transsphenoidal complications in patients with acromegaly: an analysis of inpatient data in the United States from 2002 to 2010. International forum of allergy & rhinology 5:417-422, 2015 26. Rodgers GM: Hemostatic properties of normal and perturbed vascular cells. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2:116-123, 1988 27. Roser F, Ebner FH, Ritz R, Samii M: Management of skull based meningiomas in the elderly patient. Management of skull based meningiomas in the elderly patient, 2007 28. Sabroe J, Madsen S: [Low molecular weight heparin as venous thromboembolism prophylaxis in hospitalized medical patients]. Ugeskrift for laeger 178, 2016 29. Sawaya R, Zuccarello M, Elkalliny M, Nishiyama H: Postoperative venous thromboembolism and brain tumors: Part I. Clinical profile. J Neurooncol 14:119-125, 1992 30. Sjåvik K, Bartek J, Solheim O, Ingebrigtsen T, Gulati S, Sagberg L, et al: Venous Thromboembolism Prophylaxis in Meningioma Surgery: A Population-Based Comparative Effectiveness Study of Routine Mechanical Prophylaxis with or without Preoperative Low-Molecular-Weight Heparin. World Neurosurgery 88:320-326, 2016 31. Spinazzi EF, Pines MJ, Fang CH, Raikundalia MD, Baredes S, Liu JK, et al: Impact and cost of care of venous thromboembolism following pituitary surgery. The Laryngoscope 125:1563-1567, 2015 32. Sughrue ME, Rutkowski MJ, Shangari G, Chang HQ, Parsa AT, Berger MS, et al: Risk factors for the development of serious medical complications after resection of meningiomas. Clinical article. Journal of neurosurgery 114:697-704, 2011 33. Sughrue ME, Rutkowski MJ, Shangari G, Chang QH, Parsa AT, Berger MS, et al: Risk factors for the development of serious medical complications after resection of meningiomas. Journal of Neurosurgery 114:697-704, 2011 34. Svider PF, Raikundalia MD, Pines MJ, Baredes S, Folbe AJ, Liu JK, et al: Inpatient Complications After Transsphenoidal Surgery in Cushings Versus Non-Cushings Disease Patients. Annals of Otology, Rhinology & Laryngology 125:5-11, 2015 35. Tamariz L, Harkins T, Nair V: A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data. Pharmacoepidemiology and drug safety 21 Suppl 1:154-162, 2012 36. Wiemels J, Wrensch M, Claus EB: Epidemiology and etiology of meningioma. Journal of Neuro-Oncology 99:307-314, 2010 37. Wong JM, Panchmatia JR, Ziewacz JE, Bader AM, Dunn IF, Laws ER, et al: Patterns in neurosurgical adverse events: intracranial neoplasm surgery. Neurosurgical focus 33, 2012 38. Zeng C, Wang S, Zhao Y-l, Zhang D, Wang R, Zhao J-z: [Ninety cases of postoperative complications in elderly patients after surgical removal of meningiomas]. Zhonghua yi xue za zhi 90:298-300, 2010 39. Zhang Y, Yang Y, Chen W, Liang L, Zhai Z, Guo L, et al: Hypertension associated with venous thromboembolism in patients with newly diagnosed lung cancer. Scientific reports 6:19603, 2016

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy